Jesse Boehm at the Future of Health Summit 2025: Conquering Cancer Panel
We are pleased to share that our Chief Scientific Officer, Jesse Boehm, participated as a speaker at the 2025 Future of Health Summit, hosted by the Milken Institute in Washington, DC. The Summit brought together more than 200 experts and 1,400 participants to discuss biomedical innovation, equitable access, chronic disease prevention, and the future of global health.
As part of the program, Jesse joined the panel “Conquering Cancer: Innovations, Closing Gaps and Improving Outcomes,” contributing perspectives on the power of radical collaboration and team-science models to accelerate progress for even the most overlooked cancers.
The panel explored emerging innovations in cancer detection, precision oncology, biomarkers, and strategies to ensure new technologies reach patients equitably.
You can learn more and watch the session on the Milken Institute’s website
UPDATES AND NEWS
We can prevent ovarian cancer. Women deserve the option. | USA Today
Fallopian tube removal may lower ovarian cancer risk | Good Morning America
The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-targeted Immunotherapy Strategy for Pancreatic Cancer
Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives | New York Times
BE PART OF THE MISSION
Stay Informed, Make an Impact
Subscribe
Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.
Give
Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.
